Junlai Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Junlai Li has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Changsheng Zhang
Anesthesia and Operation Center, Chinese PLA General Hospital, Beijing, China
4 shared publicationsChangtian Li
Department of Ultrasound, The Southern Building, Chinese PLA General Hospital, Beijing, China
4 shared publicationsDanfei Song
Department of Ultrasound, Second Medical Center of PLA General Hospital, Beijing, China
4 shared publicationsNan Li
Department of Ultrasound Chinese PLA General Hospital Beijing China
3 shared publications- Changtian Li
Department of Anesthesiology, First Medical Centre of Chinese PLA General Hospital, Beijing, China
2 shared publications Cheng Zhang
Department of Ultrasound Second Medical Center of Chinese PLA General Hospital Beijing China
2 shared publications
Latest Publications
- Open Access
- 1 July 2024
- Published by AME Publishing Company in Gland Surgery
- Vol. 13 (7) , 1229-1242
Prediction of malignant risk stratification model for parotid gland nodules based on clinical and conventional ultrasound features: construction and validation
Background: Ultrasound is widely used in the examination of the parotid gland, but no single ultrasound feature has demonstrated satisfactory diagnostic performance in predicting the nature of parotid nodules. Unlike the established and widely used grading systems for breast and thyroid nodules, a universally adopted and clinically accepted risk stratification system for malignancy in parotid gland nodules remains absent at present. This study aims to establish a malignant risk stratification model for parotid nodules by analyzing patients’ clinical features and conventional ultrasound image characteristics. Methods: In this study, clinical data and ultrasound images of 736 patients with parotid nodules were retrospectively analyzed. Pathological results served as the gold standard, and the patients were randomly divided into training and validation groups in a 7:3 ratio. Clinical and ultrasound features of parotid nodules in the training group were compared. Multifactor logistic regression analysis was employed to screen for risk factors of malignant nodules and quantify scores. The probability of malignant risk was assessed and classified into five grades (Grade 1, normal parotid; Grade 2, definitive benign; Grade 3, possibly benign; Grade 4, suspicious malignant; Grade 5, high probability of malignancy). The diagnostic performance of the model was assessed by using calibration curves, receiver operating characteristic curves, decision curves, and clinical impact curves. Results: Facial symptoms, unclear margin, irregular shape, microcalcification, and abnormal cervical lymph nodes were independent risk factors for malignant parotid nodules. The area under the curve of the model was 0.850 [95% confidence interval (CI): 0.816–0.879] in the training group and 0.846 (95% CI: 0.791–0.891) in the validation group. Conclusions: The malignancy risk stratification model based on clinical and ultrasound image features has a good differentiation between benign and malignant parotid nodules, which is helpful for diagnosis and guiding clinical treatment.
- 1 July 2024
- Published by AME Publishing Company in Gland Surgery
- Vol. 13 (7) , 1229-1242
Open AccessPrediction of malignant risk stratification model for parotid gland nodules based on clinical and conventional ultrasound features: construction and validation
Background: Ultrasound is widely used in the examination of the parotid gland, but no single ultrasound feature has demonstrated satisfactory diagnostic performance in predicting the nature of parotid nodules. Unlike the established and widely used grading systems for breast and thyroid nodules, a universally adopted and clinically accepted risk stratification system for malignancy in parotid gland nodules remains absent at present. This study aims to establish a malignant risk stratification model for parotid nodules by analyzing patients’ clinical features and conventional ultrasound image characteristics. Methods: In this study, clinical data and ultrasound images of 736 patients with parotid nodules were retrospectively analyzed. Pathological results served as the gold standard, and the patients were randomly divided into training and validation groups in a 7:3 ratio. Clinical and ultrasound features of parotid nodules in the training group were compared. Multifactor logistic regression analysis was employed to screen for risk factors of malignant nodules and quantify scores. The probability of malignant risk was assessed and classified into five grades (Grade 1, normal parotid; Grade 2, definitive benign; Grade 3, possibly benign; Grade 4, suspicious malignant; Grade 5, high probability of malignancy). The diagnostic performance of the model was assessed by using calibration curves, receiver operating characteristic curves, decision curves, and clinical impact curves. Results: Facial symptoms, unclear margin, irregular shape, microcalcification, and abnormal cervical lymph nodes were independent risk factors for malignant parotid nodules. The area under the curve of the model was 0.850 [95% confidence interval (CI): 0.816–0.879] in the training group and 0.846 (95% CI: 0.791–0.891) in the validation group. Conclusions: The malignancy risk stratification model based on clinical and ultrasound image features has a good differentiation between benign and malignant parotid nodules, which is helpful for diagnosis and guiding clinical treatment.
- Open Access
- 5 June 2023
- Published by AME Publishing Company in Gland Surgery
- Vol. 12 (6) , 736-748
Development and validation of a prediction model for the diagnosis of breast cancer based on clinical and ultrasonic features
Background: The aim of this study was to develop a simple and effective prediction model for calculating the probability of breast cancer by selecting clinical and sonographic features associated with breast cancer. Methods: A total of 402 lesions from 304 adult females from the ultrasound department of of PLA General Hospital from March 1st, 2020 to April 1st, 2021, were prospectively collected as the development group. The validation group included 121 lesions from 98 patients in our physical examination center from April 1st, 2021 to March 1st, 2022. Least absolute shrinkage and selection operator (LASSO) was applied to select clinical and ultrasonic variables, and R language was applied to build a web version of the interactive dynamic column line graph. The prediction model was validated by the validation group and the Breast Imaging Reporting and Data System (BI-RADS) categories. Calibration, differentiation and effectiveness were evaluated by R2, receiver operating characteristic (ROC) and decision curve analysis (DCA), respectively. Results: One hundred and seventy-nine malignant lesions and 223 benign lesions were included in the development group after exclusion and follow-up, whereas 62 malignant lesions and 59 benign lesions were enrolled in the validation group. Age, bloody nipple discharge, irregular shape, irregular border, heterogeneous echo, microcalcification, attenuation effects, decreased echo in surrounding tissues, lesions in ducts, abnormal lymph node morphology, nourishing vessel and nourishing vessel’s resistance index (RI) greater than 0.70 were selected as independent risk factors. There was no significant difference in the area under the curve (AUC) of the development group between the prediction model and the BI-RADS category (0.959 vs. 0.953, P>0.05), and so as the validation group (0.952 vs. 0.932, P>0.05). For the prediction model, R2 of the development and validation group was 0.78 and 0.72. The DCA showed that the net benefits (NB) of the development group were higher than that of the validation group (0–100% vs. 0–90%). Conclusions: A prediction model was developed with the clinical and ultrasonic features for the precise and intuitive probability of breast cancer. This could provide a reliable reference for further examination.
- 5 June 2023
- Published by AME Publishing Company in Gland Surgery
- Vol. 12 (6) , 736-748
Open AccessDevelopment and validation of a prediction model for the diagnosis of breast cancer based on clinical and ultrasonic features
Background: The aim of this study was to develop a simple and effective prediction model for calculating the probability of breast cancer by selecting clinical and sonographic features associated with breast cancer. Methods: A total of 402 lesions from 304 adult females from the ultrasound department of of PLA General Hospital from March 1st, 2020 to April 1st, 2021, were prospectively collected as the development group. The validation group included 121 lesions from 98 patients in our physical examination center from April 1st, 2021 to March 1st, 2022. Least absolute shrinkage and selection operator (LASSO) was applied to select clinical and ultrasonic variables, and R language was applied to build a web version of the interactive dynamic column line graph. The prediction model was validated by the validation group and the Breast Imaging Reporting and Data System (BI-RADS) categories. Calibration, differentiation and effectiveness were evaluated by R2, receiver operating characteristic (ROC) and decision curve analysis (DCA), respectively. Results: One hundred and seventy-nine malignant lesions and 223 benign lesions were included in the development group after exclusion and follow-up, whereas 62 malignant lesions and 59 benign lesions were enrolled in the validation group. Age, bloody nipple discharge, irregular shape, irregular border, heterogeneous echo, microcalcification, attenuation effects, decreased echo in surrounding tissues, lesions in ducts, abnormal lymph node morphology, nourishing vessel and nourishing vessel’s resistance index (RI) greater than 0.70 were selected as independent risk factors. There was no significant difference in the area under the curve (AUC) of the development group between the prediction model and the BI-RADS category (0.959 vs. 0.953, P>0.05), and so as the validation group (0.952 vs. 0.932, P>0.05). For the prediction model, R2 of the development and validation group was 0.78 and 0.72. The DCA showed that the net benefits (NB) of the development group were higher than that of the validation group (0–100% vs. 0–90%). Conclusions: A prediction model was developed with the clinical and ultrasonic features for the precise and intuitive probability of breast cancer. This could provide a reliable reference for further examination.
- Open Access
- 1 January 2023
- Published by Wiley in Mathematical Problems in Engineering
- Vol. 2023 (1)
Exploring the Clinical Benefits of Mixed‐Reality Technology for Breast Lumpectomy
This study determined the value of mixed‐reality (MR) technology for doctor‐patient communication, preoperative planning, intraoperative navigation, and tumor localization in treating patients with breast cancer. Fifty‐eight patients with breast space‐occupying lesions (16 benign and 42 malignant) who underwent breast lumpectomy at the People’s Liberation Army General Hospital of China were included in this study. The patients were randomly divided into the MR group and the computed tomography (CT) group. In the MR group, a 3D reconstruction of whole‐breast ultrasound was used to localize the spatial position of the breast lesion and was combined with the 3D reconstruction of breast MRI to determine the lesion boundaries. To improve the preciseness of surgery, a postoperative survey was conducted. The MR group exhibited a higher level of patient knowledge regarding the disease, treatment, and diagnosis (26.207 ± 1.698 points) than the CT group (19.228 ± 4.889 points) (T = 7.033; P < 0.01), and patient satisfaction with surgical results, treatment confidence, and communication methods (4.448 ± 0.572) was also higher than that of the CT group (3.172 4.448 ± 0.572) 0.602) (P < 0.05). In addition, doctors were significantly more satisfied with surgical planning and intraoperative localization when the MR technique was used (T = 8.273; P < 0.01). The use of MR technology in lumpectomy has improved patients’ understanding of surgical procedures and surgical results and has achieved positive results. This technique may provide clinical benefits.
- 1 January 2023
- Published by Wiley in Mathematical Problems in Engineering
- Vol. 2023 (1)
Open AccessExploring the Clinical Benefits of Mixed‐Reality Technology for Breast Lumpectomy
This study determined the value of mixed‐reality (MR) technology for doctor‐patient communication, preoperative planning, intraoperative navigation, and tumor localization in treating patients with breast cancer. Fifty‐eight patients with breast space‐occupying lesions (16 benign and 42 malignant) who underwent breast lumpectomy at the People’s Liberation Army General Hospital of China were included in this study. The patients were randomly divided into the MR group and the computed tomography (CT) group. In the MR group, a 3D reconstruction of whole‐breast ultrasound was used to localize the spatial position of the breast lesion and was combined with the 3D reconstruction of breast MRI to determine the lesion boundaries. To improve the preciseness of surgery, a postoperative survey was conducted. The MR group exhibited a higher level of patient knowledge regarding the disease, treatment, and diagnosis (26.207 ± 1.698 points) than the CT group (19.228 ± 4.889 points) (T = 7.033; P < 0.01), and patient satisfaction with surgical results, treatment confidence, and communication methods (4.448 ± 0.572) was also higher than that of the CT group (3.172 4.448 ± 0.572) 0.602) (P < 0.05). In addition, doctors were significantly more satisfied with surgical planning and intraoperative localization when the MR technique was used (T = 8.273; P < 0.01). The use of MR technology in lumpectomy has improved patients’ understanding of surgical procedures and surgical results and has achieved positive results. This technique may provide clinical benefits.
- Open Access
- 6 July 2022
- Published by MDPI AG in Electronics
- Vol. 11 (14) , 2116
An Intelligent Breast Ultrasound System for Diagnosis and 3D Visualization
Background: Ultrasonography is the main examination method for breast diseases. Ultrasound imaging is currently relied upon by doctors to form statements of characteristics and locations of lesions, which severely limits the completeness and effectiveness of ultrasound image information. Moreover, analyzing ultrasonography requires experienced ultrasound doctors, which are not common in hospitals. Thus, this work proposes a 3D-based breast ultrasound system, which can automatically diagnose ultrasound images of the breasts and generate a representative 3D breast lesion model through typical ultrasonography. Methods: In this system, we use a weighted ensemble method to combine three different neural networks and explore different combinations of the neural networks. On this basis, a breast locator was designed to measure and transform the spatial position of lesions. The breast ultrasound software generates a 3D visualization report through the selection and geometric transformation of the nodular model. Results: The ensemble neural network improved in all metrics compared with the classical neural network (DenseNet, AlexNet, GoogLeNet, etc.). It proved that the ensemble neural network proposed in this work can be used for intelligent diagnosis of breast ultrasound images. For 3D visualization, magnetic resonance imaging (MRI) scans were performed to achieve their 3D reconstructions. By comparing two types of visualized results (MRI and our 3D model), we determined that models generated by the 3D-based breast ultrasound system have similar nodule characteristics and spatial relationships with the MRI. Conclusions: In summary, this system implements automatic diagnosis of ultrasound images and presents lesions through 3D models, which can obtain complete and accurate ultrasound image information. Thus, it has clinical potential.
- 6 July 2022
- Published by MDPI AG in Electronics
- Vol. 11 (14) , 2116
Open AccessAn Intelligent Breast Ultrasound System for Diagnosis and 3D Visualization
Background: Ultrasonography is the main examination method for breast diseases. Ultrasound imaging is currently relied upon by doctors to form statements of characteristics and locations of lesions, which severely limits the completeness and effectiveness of ultrasound image information. Moreover, analyzing ultrasonography requires experienced ultrasound doctors, which are not common in hospitals. Thus, this work proposes a 3D-based breast ultrasound system, which can automatically diagnose ultrasound images of the breasts and generate a representative 3D breast lesion model through typical ultrasonography. Methods: In this system, we use a weighted ensemble method to combine three different neural networks and explore different combinations of the neural networks. On this basis, a breast locator was designed to measure and transform the spatial position of lesions. The breast ultrasound software generates a 3D visualization report through the selection and geometric transformation of the nodular model. Results: The ensemble neural network improved in all metrics compared with the classical neural network (DenseNet, AlexNet, GoogLeNet, etc.). It proved that the ensemble neural network proposed in this work can be used for intelligent diagnosis of breast ultrasound images. For 3D visualization, magnetic resonance imaging (MRI) scans were performed to achieve their 3D reconstructions. By comparing two types of visualized results (MRI and our 3D model), we determined that models generated by the 3D-based breast ultrasound system have similar nodule characteristics and spatial relationships with the MRI. Conclusions: In summary, this system implements automatic diagnosis of ultrasound images and presents lesions through 3D models, which can obtain complete and accurate ultrasound image information. Thus, it has clinical potential.
- 28 January 2022
- Vol. 47 (1) , 139-142
Ultrasound analysis for pancreatic panniculitis: A case report.
Pancreatic panniculitis (PP) is a necrotizing inflammation of subcutaneous fat that is a rare complication of pancreatic disease appearing in 2% to 3% of all patients. It is more common in the elderly and often affects the extremities. It presents as skin inflammation with pain and erythema nodules. We report a case of acute pancreatitis associated with PP in an old female. She was admitted for vomiting and abdominal pain for 3 days and presented with a 2-week history of erythematous subcutaneous nodules on her legs. Laboratory and ultrasonic findings revealed acute pancreatitis. High frequency ultrasound showed hypoechoic foci in subcutaneous soft tissue layer and adipose layer. Histopathological examination confirmed the diagnosis of PP. Nodules disappeared with the resolution of acute pancreatic inflammation. PP may be the first manifestation of pancreatic disease. Imaging features of this pathology are seldom described and ultrasonic diagnosis experience is worth to be accumulated.
- 28 January 2022
- Vol. 47 (1) , 139-142
Ultrasound analysis for pancreatic panniculitis: A case report.
Pancreatic panniculitis (PP) is a necrotizing inflammation of subcutaneous fat that is a rare complication of pancreatic disease appearing in 2% to 3% of all patients. It is more common in the elderly and often affects the extremities. It presents as skin inflammation with pain and erythema nodules. We report a case of acute pancreatitis associated with PP in an old female. She was admitted for vomiting and abdominal pain for 3 days and presented with a 2-week history of erythematous subcutaneous nodules on her legs. Laboratory and ultrasonic findings revealed acute pancreatitis. High frequency ultrasound showed hypoechoic foci in subcutaneous soft tissue layer and adipose layer. Histopathological examination confirmed the diagnosis of PP. Nodules disappeared with the resolution of acute pancreatic inflammation. PP may be the first manifestation of pancreatic disease. Imaging features of this pathology are seldom described and ultrasonic diagnosis experience is worth to be accumulated.
- Open Access
- 8 October 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Prognostic Significance of Ultrasound Findings of Acute Acalculous Cholecystitis for Elderly Long-Term Bedridden Patients
Background: Acute acalculous cholecystitis (AAC) is characterized by the development of cholecystitis in the gallbladder without gallstones or with small gallstones unrelated to inflammatory diseases. This disease is not rare in the elderly bedridden patients with co-morbidities and prone to develop life-threatening gangrene or perforation of gallbladder. Early imaging is essential for detecting and effectively treating AAC. This study aimed to evaluate the use of ultrasound diagnostic criteria for the diagnosis and prognosis of elderly long-term bedridden patients with suspected AAC.Methods: We retrospectively studied 374 elderly bedridden patients with clinical manifestations of AC at the acute stage of the disease. Gallbladder anomalies were found in 92 patients by ultrasound examination, which correlated with the duration time of clinical manifestations, complications, as well as therapeutic prognosis. The major and minor ultrasound criteria of AAC were made according to the Tokyo Guidelines 2018. Ultrasound results were thought to be AAC positive when they met two major criteria or one major and two minor criteria.Results: Forty-three (46.7%) of the 92 patients presented with AAC (+) test results based on the ultrasound criteria, with a higher incidence of complications (27.9%) than AAC (–) patients (0%; P < 0.001). The median length of symptoms (8 vs. 4 days, P < 0.001) and duration of antibiotic therapy (13 vs. 5 days, P < 0.001) were longer in the AAC (+) group.Conclusions: The ultrasound-based AAC (+) group often had a worse prognosis than the AAC (–) group. Therefore, patients from the AAC (+) group should receive a follow-up ultrasound examination to detect disease progression early.
- 8 October 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Open AccessPrognostic Significance of Ultrasound Findings of Acute Acalculous Cholecystitis for Elderly Long-Term Bedridden Patients
Background: Acute acalculous cholecystitis (AAC) is characterized by the development of cholecystitis in the gallbladder without gallstones or with small gallstones unrelated to inflammatory diseases. This disease is not rare in the elderly bedridden patients with co-morbidities and prone to develop life-threatening gangrene or perforation of gallbladder. Early imaging is essential for detecting and effectively treating AAC. This study aimed to evaluate the use of ultrasound diagnostic criteria for the diagnosis and prognosis of elderly long-term bedridden patients with suspected AAC.Methods: We retrospectively studied 374 elderly bedridden patients with clinical manifestations of AC at the acute stage of the disease. Gallbladder anomalies were found in 92 patients by ultrasound examination, which correlated with the duration time of clinical manifestations, complications, as well as therapeutic prognosis. The major and minor ultrasound criteria of AAC were made according to the Tokyo Guidelines 2018. Ultrasound results were thought to be AAC positive when they met two major criteria or one major and two minor criteria.Results: Forty-three (46.7%) of the 92 patients presented with AAC (+) test results based on the ultrasound criteria, with a higher incidence of complications (27.9%) than AAC (–) patients (0%; P < 0.001). The median length of symptoms (8 vs. 4 days, P < 0.001) and duration of antibiotic therapy (13 vs. 5 days, P < 0.001) were longer in the AAC (+) group.Conclusions: The ultrasound-based AAC (+) group often had a worse prognosis than the AAC (–) group. Therefore, patients from the AAC (+) group should receive a follow-up ultrasound examination to detect disease progression early.
- 18 July 2020
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 40 (1) , 163-173
A Safety Study of the Effects of 2‐Dimensional Shear Wave Elastography on Synaptic Morphologic Characteristics and Function in the Hippocampus of Neonatal Mice
Objectives The aim of this study was to determine the effects of 2‐dimensional (2D) shear wave elastography (SWE) on synaptic morphologic characteristics and function in the neonatal mouse hippocampus and whether it affects the capacity for learning and memory later in life. Methods We divided neonatal mice into a control group and a 2D SWE group scanned for 10, 20, or 30 minutes. Hippocampal morphologic characteristics were assessed by hematoxylin–eosin and Nissl staining. Ultrastructures of hippocampal neurons were visualized by electron microscopy. Protein and messenger RNA expression levels of synaptophysin, N ‐methyl‐d ‐aspartate receptor 1 (NMDAR1), NMDAR2A, and NMDAR2B were quantified by a western blot and polymerase chain reaction, respectively. Learning and memory of adult mice were evaluated by the Morris water maze and the novel object recognition task. Results Compared with the control group, the hippocampal morphologic characteristics of the experimental groups did not differ under light microscopy, and the synaptic structures assessed by electron microscopy appeared normal. Western blot and polymerase chain reaction results showed that expression of synaptophysin, NMDAR1, NMDAR2A, and NMDAR2B were downregulated after exposure to 2D SWE, but there were no statistical differences between the experimental groups. This downregulation disappeared within 24 hours. The results of the Morris water maze and novel object recognition suggested that the 2D SWE scanning on neonatal mice had no effect on learning and memory in adulthood. Conclusions This study demonstrated that when the mice were exposed to neonatal cranial ultrasound by 2D SWE lasting for longer than 10 minutes, the expression of genes involved in synaptic function was affected, but this effect lasted no longer than 24 hours and did not affect learning and memory in adulthood.
- 18 July 2020
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 40 (1) , 163-173
A Safety Study of the Effects of 2‐Dimensional Shear Wave Elastography on Synaptic Morphologic Characteristics and Function in the Hippocampus of Neonatal Mice
Objectives The aim of this study was to determine the effects of 2‐dimensional (2D) shear wave elastography (SWE) on synaptic morphologic characteristics and function in the neonatal mouse hippocampus and whether it affects the capacity for learning and memory later in life. Methods We divided neonatal mice into a control group and a 2D SWE group scanned for 10, 20, or 30 minutes. Hippocampal morphologic characteristics were assessed by hematoxylin–eosin and Nissl staining. Ultrastructures of hippocampal neurons were visualized by electron microscopy. Protein and messenger RNA expression levels of synaptophysin, N ‐methyl‐d ‐aspartate receptor 1 (NMDAR1), NMDAR2A, and NMDAR2B were quantified by a western blot and polymerase chain reaction, respectively. Learning and memory of adult mice were evaluated by the Morris water maze and the novel object recognition task. Results Compared with the control group, the hippocampal morphologic characteristics of the experimental groups did not differ under light microscopy, and the synaptic structures assessed by electron microscopy appeared normal. Western blot and polymerase chain reaction results showed that expression of synaptophysin, NMDAR1, NMDAR2A, and NMDAR2B were downregulated after exposure to 2D SWE, but there were no statistical differences between the experimental groups. This downregulation disappeared within 24 hours. The results of the Morris water maze and novel object recognition suggested that the 2D SWE scanning on neonatal mice had no effect on learning and memory in adulthood. Conclusions This study demonstrated that when the mice were exposed to neonatal cranial ultrasound by 2D SWE lasting for longer than 10 minutes, the expression of genes involved in synaptic function was affected, but this effect lasted no longer than 24 hours and did not affect learning and memory in adulthood.
- Open Access
- 1 July 2020
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 27, 102204
Precise visual distinction of brain glioma from normal tissues via targeted photoacoustic and fluorescence navigation
- 1 July 2020
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 27, 102204
Open AccessPrecise visual distinction of brain glioma from normal tissues via targeted photoacoustic and fluorescence navigation
- 30 June 2020
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e924832-1-e924832-7
Effects of 2D-Shear Wave Elastography on Brain-Derived Neurotrophic Factor (BDNF) in the Brains of Neonatal Mice and Exploration of the Mechanism
Background: The aim of this study was to explore the effect and duration of 2-dimensional shear wave elastography (2D-SWE) irradiation on the expression of brain-derived neurotrophic factor (BDNF) in the brains of neonatal mice and to preliminarily investigate whether its mechanism is neuronal apoptosis. Material/Methods: Neonatal mice (within 48 hours of birth) were subjected to 2D-SWE irradiation of the brain for 10 minutes (group S1), 20 minutes (group S2), and 30 minutes (group S3). The mice were sacrificed immediately after irradiation or 24 hours after irradiation. Brains were collected for real-time polymerase chain reaction (RT-PCR) and western blot experiments to determine the expression of BDNF in each group. TdT-mediated dUTP nick-end labeling (TUNEL) was performed to observe neuronal apoptosis in the brain. Results: The results of PCR and western blots from the brains of neonatal mice that were sacrificed immediately after irradiation show that S1, S2, and S3 were significantly different from those in the control group. The PCR and western blot results of brain tissues from neonatal mice sacrificed at 24 hours after irradiation showed that there was no significant difference between the S1, S2, S3, and control groups. The results of TUNEL experiments showed that there was no statistically significant difference in the number of apoptotic neurons between the S1, S2, S3, and control groups. Conclusions: 2D-SWE irradiation of neonatal mice for more than 10 minutes downregulated the expression of BDNF. This effect disappeared within 24 hours after the irradiation, and the 2D-SWE scan seemed not to induce neuronal apoptosis.
- 30 June 2020
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e924832-1-e924832-7
Effects of 2D-Shear Wave Elastography on Brain-Derived Neurotrophic Factor (BDNF) in the Brains of Neonatal Mice and Exploration of the Mechanism
Background: The aim of this study was to explore the effect and duration of 2-dimensional shear wave elastography (2D-SWE) irradiation on the expression of brain-derived neurotrophic factor (BDNF) in the brains of neonatal mice and to preliminarily investigate whether its mechanism is neuronal apoptosis. Material/Methods: Neonatal mice (within 48 hours of birth) were subjected to 2D-SWE irradiation of the brain for 10 minutes (group S1), 20 minutes (group S2), and 30 minutes (group S3). The mice were sacrificed immediately after irradiation or 24 hours after irradiation. Brains were collected for real-time polymerase chain reaction (RT-PCR) and western blot experiments to determine the expression of BDNF in each group. TdT-mediated dUTP nick-end labeling (TUNEL) was performed to observe neuronal apoptosis in the brain. Results: The results of PCR and western blots from the brains of neonatal mice that were sacrificed immediately after irradiation show that S1, S2, and S3 were significantly different from those in the control group. The PCR and western blot results of brain tissues from neonatal mice sacrificed at 24 hours after irradiation showed that there was no significant difference between the S1, S2, S3, and control groups. The results of TUNEL experiments showed that there was no statistically significant difference in the number of apoptotic neurons between the S1, S2, S3, and control groups. Conclusions: 2D-SWE irradiation of neonatal mice for more than 10 minutes downregulated the expression of BDNF. This effect disappeared within 24 hours after the irradiation, and the 2D-SWE scan seemed not to induce neuronal apoptosis.
- Open Access
- 21 May 2020
- Published by Wiley in Cancer Medicine
- Vol. 9 (14) , 4971-4979
HIF‐1α interacts with Kindlin‐2 and influences breast cancer elasticity: A study based on shear wave elastography imaging
Breast cancer was the most frequent and the second most deadly cancer in women in 2018 in China; thus, early diagnosis of breast cancer is important. Studies have reported that tissue stiffness promotes cancer progression through increased collagen or fibrosis. Shear wave elastography (SWE) is a technique for measuring tissue stiffness. However, the mechanisms underlying cancer tissue stiffness or fibrosis are not entirely clear. Hypoxia‐inducible factor 1 (HIF‐1α) is expressed in response to hypoxia and contributes to tumor progression and metastasis. Kindlin‐2 is an important co‐activator of integrin. We have reported that Kindlin‐2 influences breast cancer stiffness and metastasis. In this study, SWE was used to determine the maximum elasticity (Emax) of patients before operation or core needle biopsy. The specimens were used for staining. Knockdown, overexpression, co‐immunoprecipitation, and immunofluorescence assays were used to explore the relationship between HIF‐1α and Kindlin‐2. We found that HIF‐1α and Kindlin‐2 were highly expressed in invasive breast cancer and that the expression levels of HIF‐1α and Kindlin‐2 were correlated with Emax. HIF‐1α interacts with Kindlin‐2. Besides, HIF‐1α and Kindlin‐2 influence the expression of P4HA1, an important protein in collagen biogenesis through the integrin/FAK pathway. Our study first identified a new mechanism of invasive breast cancer stiffness by linking HIF‐1α and Kindlin‐2 to collagen biogenesis. Therefore, based on SWE, Emax could be a physical biomarker of invasive breast cancer for early, noninvasive diagnosis, and HIF‐1α and Kindlin‐2 could be pathological markers for early diagnosis and targeted therapy.
- 21 May 2020
- Published by Wiley in Cancer Medicine
- Vol. 9 (14) , 4971-4979
Open AccessHIF‐1α interacts with Kindlin‐2 and influences breast cancer elasticity: A study based on shear wave elastography imaging
Breast cancer was the most frequent and the second most deadly cancer in women in 2018 in China; thus, early diagnosis of breast cancer is important. Studies have reported that tissue stiffness promotes cancer progression through increased collagen or fibrosis. Shear wave elastography (SWE) is a technique for measuring tissue stiffness. However, the mechanisms underlying cancer tissue stiffness or fibrosis are not entirely clear. Hypoxia‐inducible factor 1 (HIF‐1α) is expressed in response to hypoxia and contributes to tumor progression and metastasis. Kindlin‐2 is an important co‐activator of integrin. We have reported that Kindlin‐2 influences breast cancer stiffness and metastasis. In this study, SWE was used to determine the maximum elasticity (Emax) of patients before operation or core needle biopsy. The specimens were used for staining. Knockdown, overexpression, co‐immunoprecipitation, and immunofluorescence assays were used to explore the relationship between HIF‐1α and Kindlin‐2. We found that HIF‐1α and Kindlin‐2 were highly expressed in invasive breast cancer and that the expression levels of HIF‐1α and Kindlin‐2 were correlated with Emax. HIF‐1α interacts with Kindlin‐2. Besides, HIF‐1α and Kindlin‐2 influence the expression of P4HA1, an important protein in collagen biogenesis through the integrin/FAK pathway. Our study first identified a new mechanism of invasive breast cancer stiffness by linking HIF‐1α and Kindlin‐2 to collagen biogenesis. Therefore, based on SWE, Emax could be a physical biomarker of invasive breast cancer for early, noninvasive diagnosis, and HIF‐1α and Kindlin‐2 could be pathological markers for early diagnosis and targeted therapy.